本页面由Tiger Trade Technology Pte. Ltd.提供服务

Addex Therapeutics Ltd

6.99
+0.51107.89%
成交量:1,603.00
成交额:1.09万
市值:861.29万
市盈率:-0.78
高:6.99
开:6.55
低:6.55
收:6.48
52周最高:12.05
52周最低:5.41
股本:123.20万
流通股本:104.18万
量比:0.25
换手率:0.15%
股息:- -
股息率:- -
每股收益(TTM):-8.9530
每股收益(LYR):9.52
净资产收益率:-72.84%
总资产收益率:-15.90%
市净率:1.14
市盈率(LYR):0.73

数据加载中...

2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/25

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/19

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/08/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/29

SEC问询函

CORRESP [Cover] - Correspondence
2022/03/10

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/18

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/01/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/07

招股说明书

F-1 - Registration statement for certain foreign private issuers
2021/09/08

超过5%披露

Addex Therapeutics Ltd.
2021/04/12

SEC问询函

CORRESP [Cover] - Correspondence